Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports (CCI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT00921141
First received: June 15, 2009
Last updated: July 20, 2012
Last verified: July 2012
  Purpose
This is a prospective, descriptive and observational study of the anticancer center practice

Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports : Cohort and Prospective Study

Further study details as provided by Centre Oscar Lambret:

Primary Outcome Measures:
  • Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change [ Time Frame: Until the implantable central venous access ports removal ]

Secondary Outcome Measures:
  • Brief description of the different risk factor for morbidity [ Time Frame: Until the implantable central venous access ports removal ]
  • Assessment of the implantable central venous access ports ease-of-use for nurses according to the modalities of implementation and patient features [ Time Frame: Until the implantable central venous access ports removal ]
  • Assessment of the patient quality of life [ Time Frame: Before central venous access ports implementation, at the first day of chemotherapy, and during the cycle 4 of chemotherapy ]

Enrollment: 815
Study Start Date: May 2006
Study Completion Date: April 2009
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
study population
Patient with cancer requiring a long-term central venous catheter

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All the patients requiring the implementation of a catheter in an anticancerous center
Criteria

Inclusion Criteria:

  • Patient with any cancer, requiring a central venous catheter
  • No contraindication for any surgery with local or complete anaesthesia

Exclusion Criteria:

  • Previous Xylocaine or Lidocaine allergy
  • Clinic superior vena cava syndrome
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00921141

Locations
France
Centre Oscar Lambret
Lille, France, 59020
Sponsors and Collaborators
Centre Oscar Lambret
Investigators
Principal Investigator: Fabrice NARDUCCI, MD Centre Oscar Lambret
  More Information

Responsible Party: Centre Oscar Lambret
ClinicalTrials.gov Identifier: NCT00921141     History of Changes
Other Study ID Numbers: CCI
Study First Received: June 15, 2009
Last Updated: July 20, 2012

Keywords provided by Centre Oscar Lambret:
Implantable central venous access ports, cancer

ClinicalTrials.gov processed this record on April 24, 2017